| Clinical pharmacokinetics of metformin GG Graham, J Punt, M Arora, RO Day, MP Doogue, J Duong, TJ Furlong, ... Clinical pharmacokinetics 50 (2), 81-98, 2011 | 1608 | 2011 |
| Relative hyperglycemia, a marker of critical illness: introducing the stress hyperglycemia ratio GW Roberts, SJ Quinn, N Valentine, T Alhawassi, H O'Dea, SN Stranks, ... The Journal of Clinical Endocrinology & Metabolism 100 (12), 4490-4497, 2015 | 507 | 2015 |
| A longitudinal study of plasma and urinary cortisol in pregnancy and postpartum C Jung, JT Ho, DJ Torpy, A Rogers, M Doogue, JG Lewis, RJ Czajko, ... The Journal of Clinical Endocrinology & Metabolism 96 (5), 1533-1540, 2011 | 493 | 2011 |
| Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and … JH Martin, R Norris, M Barras, J Roberts, R Morris, M Doogue, GRD Jones The Clinical biochemist Reviews 31 (1), 21, 2010 | 218 | 2010 |
| The ABCD of clinical pharmacokinetics MP Doogue, TM Polasek Therapeutic advances in drug safety 4 (1), 5-7, 2013 | 210 | 2013 |
| Chronic kidney disease and automatic reporting of estimated glomerular filtration rate: new developments and revised recommendations DW Johnson, GRD Jones, TH Mathew, MJ Ludlow, MP Doogue, MD Jose, ... Medical journal of Australia 197 (4), 222-223, 2012 | 184 | 2012 |
| Drug interactions: principles and practice BD Snyder, TM Polasek, MP Doogue Australian prescriber 35 (3), 2012 | 162 | 2012 |
| Antimicrobial treatment options for granulomatous mastitis caused by Corynebacterium species HC Dobinson, TP Anderson, ST Chambers, MP Doogue, L Seaward, ... Journal of clinical microbiology 53 (9), 2895-2899, 2015 | 161 | 2015 |
| Drug dosing in renal disease MP Doogue, TM Polasek The Clinical Biochemist Reviews 32 (2), 69, 2011 | 130 | 2011 |
| Perpetrators of pharmacokinetic drug–drug interactions arising from altered cytochrome P450 activity: a criteria‐based assessment TM Polasek, FPY Lin, JO Miners, MP Doogue British journal of clinical pharmacology 71 (5), 727-736, 2011 | 128 | 2011 |
| Iron polymaltose-induced FGF23 elevation complicated by hypophosphataemic osteomalacia BJ Schouten, MP Doogue, SG Soule, PJ Hunt Annals of clinical biochemistry 46 (2), 167-169, 2009 | 108 | 2009 |
| Priority points and cardiac events while waiting for coronary bypass surgery NW Jackson, MP Doogue, JM Elliott Heart 81 (4), 367-373, 1999 | 94 | 1999 |
| Predicted metabolic drug clearance with increasing adult age TM Polasek, F Patel, BP Jensen, MJ Sorich, MD Wiese, MP Doogue British journal of clinical pharmacology 75 (4), 1019-1028, 2013 | 81 | 2013 |
| Detecting undiagnosed diabetes using glycated haemoglobin: an automated screening test in hospitalised patients NA Valentine, TM Alhawassi, GW Roberts, PP Vora, SN Stranks, ... Medical journal of Australia 194 (4), 160-164, 2011 | 70 | 2011 |
| Sertraline in symptomatic chronic breathlessness: a double blind, randomised trial DC Currow, M Ekström, S Louw, J Hill, B Fazekas, K Clark, PM Davidson, ... European Respiratory Journal 53 (1), 2019 | 63 | 2019 |
| Advances in biochemical screening for phaeochromocytoma using biogenic amines MJ Whiting, MP Doogue The Clinical Biochemist Reviews 30 (1), 3, 2009 | 58 | 2009 |
| Pharmacovigilance in hospice/palliative care: net effect of haloperidol for delirium GB Crawford, M Agar M, SJ Quinn, J Phillips, C Litster, N Michael, ... Journal of palliative medicine 16 (11), 1335-1341, 2013 | 56 | 2013 |
| Recurrent gallstone ileus: underestimated MP Doogue, CK Choong, FA Frizelle The Australian and New Zealand journal of surgery 68 (11), 755-756, 1998 | 54 | 1998 |
| Preanalytical stability of piperacillin, tazobactam, meropenem, and ceftazidime in plasma and whole blood using liquid chromatography–tandem mass spectrometry JS Mortensen, BP Jensen, M Zhang, M Doogue Therapeutic drug monitoring 41 (4), 538-543, 2019 | 51 | 2019 |
| Metformin increases plasma ghrelin in Type 2 diabetes MP Doogue, EJ Begg, MP Moore, H Lunt, CJ Pemberton, M Zhang British journal of clinical pharmacology 68 (6), 875-882, 2009 | 50 | 2009 |
Carl KirkpatrickMonash UniversityVerified email at monash.edu
